HC Wainwright & Co. Maintains Buy on Ocugen, Lowers Price Target to $9.5

Benzinga · 1d ago
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Ocugen (NASDAQ:OCGN) with a Buy and lowers the price target from $10 to $9.5.